The Ventricular Assist Device market is projected to reach US$ 10.5 Bn by 2030. And registering a CAGR of around 20.3% over the forecast period 2021 – 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38413
Growth Factors
The rapidly growing global geriatric population is susceptible to chronic medical ailments such as diabetes, neurological disorders, cardiovascular diseases, stroke, and end-stage cardiac failure. The rising risks of organ failures and the growing demand for organ transplants due to these chronic ailments are contributing to the growth of the market for Ventricular Assist Devices (VADs). The development of innovative products and sophisticated miniature devices incorporated with features, such as infection control techniques, is expected to provide an impetus to the growth. The numerous benefits associated with the use of VADs, such as increased survival rate, durability, and functionality, are supporting the growing rate of adoption, and thereby boosting the market for VAD.
The growing rate of globalization, increasing pursual of unhealthy lifestyle habits, minimal physical activity, increased consumption of junk food and beverages, and and alcohol consumption if leading to the high global prevalence of cardiovascular diseases.
Report Highlights
The market for VADs is expected to witness significant growth over the forecast period owing to the increasing prevalence of cardiovascular diseases and shortage of transplant organs
the Left Ventricular Assist Devices (LVAD) segment dominated the market for VAD and accounted for the largest revenue share of 90.5%. This growth is owing to the numerous procedures of LVAD implantations recorded amongst patients.
The Bi-ventricular Assist Devices (BiVAD) segment is anticipated to register the fastest growth rate of 28.7% over the forthcoming years. The increased use of pneumatically driven BiVADs in TAH transplantation is expected to boost product demand.
the non-pulsatile or continuous flow segment dominated the market for VAD and accounted for the largest revenue share of 99.5% owing to the benefits of the continuous flow VADs over pulsatile VADs. Continuous flow VADs have minimal noise, lesser rotating parts, lower maintenance, and rare replacements.
the implantable devices segment dominated the market for VAD and accounted for the largest revenue share of 81.5%. This growth is owing to the rising preference for long-term therapy methods by patients ineligible for heart transplant interventions, and therefore this segment is anticipated to grow at a lucrative rate over the forthcoming years.
the destination therapy segment dominated the market for VAD and accounted for the largest revenue share of 53.1%. This growth is attributable to the increase in end-stage cardiac failure incidences and cardiovascular diseases.
North America dominated the ventricular assist devices market and accounted for the largest revenue share of 64.1% in 2020. The availability of regulated reimbursement policies and coverages, increasing awareness regarding VADs such as bridge-to-recovery, destination therapies, and bridge-to-transplant are anticipated to drive the market for VAD in the forthcoming years.
| Report Coverage | Details |
| Market Size | US$ 10.5 billion by 2030 |
| Growth Rate | CAGR of 20.3% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Type of Flow, Design, Application |
| Regional Scope | North America, Latin America, Europe, Asia Pacific, MEA |
| Companies Mentioned | Abiomed; Medtronic; Abbott; Berlin Heart; Cardiac Assist, Inc.; Jarvik Heart, Inc.; ReliantHeart, Inc.; Sun Medical Technology Research Corp |
Key Players
- Abiomed
- Medtronic
- Abbott
- Berlin Heart
- Cardiac Assist, Inc.
- Jarvik Heart, Inc.
- ReliantHeart, Inc.
- Sun Medical Technology Research Corp
Market Segmentation
- Product Outlook
- Left Ventricular Assist Device
- Right Ventricular Assist Device
- Bi-Ventricular Assist Device
- Total Artificial Heart
- Type Of Flow Outlook
- Pulsatile Flow
- Continuous Flow
- Application Outlook
- Bridge to Transplant
- Destination Therapy
- Others (Bridge to Recovery, Bridge to Candidacy, and Others)
- Design Outlook
- Implantable Ventricular Assist Device
- Transcutaneous Ventricular Assist Device
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Spain
- Italy
- France
- Russia
- Asia Pacific
- Japan
- China
- India
- Singapore
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38413
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Ventricular Assist Device Market, By Product
7.1. Ventricular Assist Device Market, by Product, 2020-2030
7.1.1. Left Ventricular Assist Device
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Right Ventricular Assist Device
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Bi-Ventricular Assist Device
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Total Artificial Heart
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Ventricular Assist Device Market, By Type Of Flow
8.1. Ventricular Assist Device Market, by Type Of Flow, 2020-2030
8.1.1. Pulsatile Flow
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Continuous Flow
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Ventricular Assist Device Market, By Application
9.1. Ventricular Assist Device Market, by Application, 2020-2030
9.1.1. Bridge to Transplant
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Destination Therapy
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Ventricular Assist Device Market, By Design
10.1. Ventricular Assist Device Market, by Design, 2020-2030
10.1.1. Implantable Ventricular Assist Device
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Transcutaneous Ventricular Assist Device
10.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Ventricular Assist Device Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.1.3. Market Revenue and Forecast, by Application (2016-2030)
11.1.4. Market Revenue and Forecast, by Design (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2016-2030)
11.1.5.4. Market Revenue and Forecast, by Design (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2016-2030)
11.1.6.4. Market Revenue and Forecast, by Design (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.2.3. Market Revenue and Forecast, by Application (2016-2030)
11.2.4. Market Revenue and Forecast, by Design (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2016-2030)
11.2.5.4. Market Revenue and Forecast, by Design (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2016-2030)
11.2.6.4. Market Revenue and Forecast, by Design (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2016-2030)
11.2.7.4. Market Revenue and Forecast, by Design (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2016-2030)
11.2.8.4. Market Revenue and Forecast, by Design (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.3.3. Market Revenue and Forecast, by Application (2016-2030)
11.3.4. Market Revenue and Forecast, by Design (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2016-2030)
11.3.5.4. Market Revenue and Forecast, by Design (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2016-2030)
11.3.6.4. Market Revenue and Forecast, by Design (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2016-2030)
11.3.7.4. Market Revenue and Forecast, by Design (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2016-2030)
11.3.8.4. Market Revenue and Forecast, by Design (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.4.3. Market Revenue and Forecast, by Application (2016-2030)
11.4.4. Market Revenue and Forecast, by Design (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2016-2030)
11.4.5.4. Market Revenue and Forecast, by Design (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2016-2030)
11.4.6.4. Market Revenue and Forecast, by Design (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2016-2030)
11.4.7.4. Market Revenue and Forecast, by Design (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2016-2030)
11.4.8.4. Market Revenue and Forecast, by Design (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.5.3. Market Revenue and Forecast, by Application (2016-2030)
11.5.4. Market Revenue and Forecast, by Design (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2016-2030)
11.5.5.4. Market Revenue and Forecast, by Design (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Type Of Flow (2016-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2016-2030)
11.5.6.4. Market Revenue and Forecast, by Design (2016-2030)
Chapter 12. Company Profiles
12.1. Abiomed
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medtronic
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Abbott.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Berlin Heart
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cardiac Assist, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Jarvik Heart, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ReliantHeart, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sun Medical Technology Research Corp
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38413
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
